Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange about Investor Presentation

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated August 06, 2026, titled 'Press Release on Un-audited results for Quarter ended June 30, 2026'.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on August 06, 2026.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has submitted its financial results for the period ended June 30, 2026.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange about the schedule of an Analyst / Institutional Investor Meeting to be held on August 12, 2026, at EMKAY Confluence 2026 in Mumbai.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange about the schedule of a meet.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange regarding allotment of 100,987 securities pursuant to ESOP/ESPS at its meeting held on July 22, 2026.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange about a copy of newspaper publication.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange regarding Notice of Postal Ballot for the appointment of two Independent Directors, Mr. Satyanarayana Murthy Chavali and Mr. Dipinder Singh Sekhon, through remote e-voting.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the details of securities dematerialized or rematerialized during the quarter ended June 30, 2026, to all stock exchanges where the company's shares are listed.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange about Options to purchase securities under the VDCL Employee Stock Option Plan 2018. The Nomination & Remuneration Committee has made a grant of 90,000 ESOPs, which are convertible into 90,000 equity shares of face value ₹1/- each. The grant is in line with the provisions of the SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has appointed Mr. Narasimha Raju K.A. as its Chief Financial Officer, effective July 09, 2026.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange regarding Outcome of Board Meeting held on July 09, 2026, where the Board of Directors has considered and approved the appointment of Mr. Narasimha Raju K.A. as Chief Financial Officer of the Company, effective July 09, 2026.

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.